Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.
Castellano E, Samba C, Esteso G, Simpson L, Vendrame E, García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Linares A, Leibar A, Ranganath T, Reyburn HT, Martínez-Piñeiro L, Blish C, Valés-Gómez M. Castellano E, et al. Among authors: lopez cobo s. Front Immunol. 2022 Sep 15;13:970931. doi: 10.3389/fimmu.2022.970931. eCollection 2022. Front Immunol. 2022. PMID: 36189320 Free PMC article.
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.
García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Esteso G, Romera-Cárdenas G, Rey M, Cassady-Cain RL, Linares A, Valés-Gómez A, Reyburn HT, Martínez-Piñeiro L, Valés-Gómez M. García-Cuesta EM, et al. Front Immunol. 2015 Jun 8;6:284. doi: 10.3389/fimmu.2015.00284. eCollection 2015. Front Immunol. 2015. PMID: 26106390 Free PMC article.
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.
Ashiru O, Esteso G, García-Cuesta EM, Castellano E, Samba C, Escudero-López E, López-Cobo S, Álvarez-Maestro M, Linares A, Ho MM, Leibar A, Martínez-Piñeiro L, Valés-Gómez M. Ashiru O, et al. Among authors: lopez cobo s. Cancers (Basel). 2019 Jul 4;11(7):940. doi: 10.3390/cancers11070940. Cancers (Basel). 2019. PMID: 31277459 Free PMC article.
Ionomycin Treatment Renders NK Cells Hyporesponsive.
Romera-Cárdenas G, Thomas LM, Lopez-Cobo S, García-Cuesta EM, Long EO, Reyburn HT. Romera-Cárdenas G, et al. PLoS One. 2016 Mar 23;11(3):e0150998. doi: 10.1371/journal.pone.0150998. eCollection 2016. PLoS One. 2016. PMID: 27007115 Free PMC article.
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient.
Valés-Gómez M, Esteso G, Aydogmus C, Blázquez-Moreno A, Marín AV, Briones AC, Garcillán B, García-Cuesta EM, López Cobo S, Haskologlu S, Moraru M, Cipe F, Dobbs K, Dogu F, Parolini S, Notarangelo LD, Vilches C, Recio MJ, Regueiro JR, Ikinciogullari A, Reyburn HT. Valés-Gómez M, et al. J Allergy Clin Immunol. 2016 Mar;137(3):942-5.e4. doi: 10.1016/j.jaci.2015.07.051. Epub 2015 Nov 2. J Allergy Clin Immunol. 2016. PMID: 26542031 No abstract available.
16 results